首页> 美国卫生研究院文献>Scientific Reports >International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I)
【2h】

International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I)

机译:国际慢性眼移植物抗宿主病(GVHD)共识小组:慢性GVHD的建议诊断标准(第一部分)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The International Chronic Ocular GVHD Consensus Group held 4 working meetings to define new diagnostic metrics for chronic ocular graft-versus-host disease (GVHD). After considering the factors currently used to diagnose chronic ocular GVHD, the Consensus Group identified 4 subjective and objective variables to measure in patients following allogeneic hematopoietic stem cell transplantation (HSCT): OSDI, Schirmer's score without anesthesia, corneal staining, and conjunctival injection. Each variable was scored 0–2 or 0–3, with a maximum composite score of 11. Consideration was also given to the presence or the absence of systemic GVHD. On the basis of their composite score and the presence or absence of systemic GVHD, patients were assigned to one of three diagnostic categories: NO, PROBABLE, or DEFINITE ocular GVHD. New diagnostic criteria for chronic ocular GVHD are presented by the Consensus Group. Validation studies are needed to identify the best combination of the proposed metrics to maximize diagnostic sensitivity and specificity.
机译:国际慢性眼GVHD共识小组举行了4次工作会议,以定义针对慢性眼移植物抗宿主病(GVHD)的新诊断指标。在考虑了目前用于诊断慢性眼GVHD的因素之后,共识小组确定了在异基因造血干细胞移植(HSCT)后患者中要测量的4个主观和客观变量:OSDI,无麻醉Schirmer评分,角膜染色和结膜注射。每个变量的评分为0–2或0–3,最大综合评分为11。还考虑了系统性GVHD的存在与否。根据患者的综合评分以及是否存在全身性GVHD,将患者分为以下三种诊断类别之一:NO,PROBABLE或DEFINITE眼GVHD。共识小组提出了慢性眼GVHD的新诊断标准。需要进行验证研究来确定所建议度量的最佳组合,以最大程度地提高诊断敏感性和特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号